Antispetic

Manufacturer: Demoulas Super Markets, Inc | Nice-Pak Products, LLC
Effective date: 2026-02-03
Label type: HUMAN OTC DRUG LABEL
Version: 14
Source: full-release
Hydrated at: 2026-06-01 01:36:24

Label at a glance#

ProductAntispetic

Active ingredientCETYLPYRIDINIUM CHLORIDE

Label structure13 sections

Dosage and administration

adults and children 6 years & older: rinse for 30 seconds with 20 mL (4 teaspoonfuls) twice a day do not swallow children 6 years to under 12 years of age: supervise use when used after brushing, rinse mouth with water first children under 6 years of age: do not use

Label contents#

Full prescribing information#

Claims

SPL UNCLASSIFIED SECTION

For better oral hygiene and fresher breath

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Cetylpyridinium chloride 0.07%

Purpose

OTC - PURPOSE SECTION

Antigingivitis, Antiplaque

Use

INDICATIONS & USAGE SECTION

helps control plaque that leads to gingivitis

Warnings

WARNINGS SECTION

for this product

Stop use and ask a dentist if

OTC - STOP USE SECTION

gingivitis, gleeding or redness persists for more than 2 weeks
you have painful or swollen gums, pus from the gum line, loose teeth or increased spacing between the teeth. These may be signs or symptoms of periodontitis, a serious form of gum disease.

Keep out of reach of children under 6 years of age.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If more than used for rinsing is accidentally swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children 6 years & older: rinse for 30 seconds with 20 mL (4 teaspoonfuls) twice a day
do not swallow
children 6 years to under 12 years of age: supervise use
when used after brushing, rinse mouth with water first
children under 6 years of age: do not use

Other information

SPL UNCLASSIFIED SECTION

this rinse is not intended to replace brushing or flossing

Inactive ingredients

INACTIVE INGREDIENT SECTION

water, glycerin, flavor, poloxamer 188, sodium saccharin, propylene glycol, sodium benzoate, sucralose, benzoic acid, blue 1

Disclaimers

SPL UNCLASSIFIED SECTION

This rinse may cause temporary staining to the surface of teeth.

This is not harmful, and adequate brushing may prevent its occurrence.

*This product is not manufactured or distributed by Procter & Gamble, distributor of Crest ^®Pro-Health Multi-Protection Alcohol Free Rinse - Refreshing Clean Mint

ADVERSE REACTION

ADVERSE REACTIONS SECTION

DISTRIBUTED BY

DEMOULAS SUPER MARKETS, INC.

875 EAST STREET

TEWKSBURY, MA 01876

principal display panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

"MORE FOR YOUR DOLLAR"

MARKET BASKET ^®

Sealed with printed neckband for your protection

Compare to active ingredient in Crest ^®Pro-Health Rinse*

Mulit-Action Alcohol-Free

Antiseptic Oral Rinse with CPC

Antigingivitis/Antiplaque

KILLS GERMS
HELPS PREVENT PLAQUE
HELPS PREVENT GINGIVITIS
HELPS KEEP TEETH FEELING CLEAN
FRESHENS BREATH
NO BURN OF ALCOHOL

Zesty Mint

1 L (33.8 FL OZ)

image descriptionimage description

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1100924	cetylpyridinium chloride 0.07 % Oral Rinse	PSN	14
1100924	cetylpyridinium chloride 0.7 MG/ML Mouthwash	SCD	14
1100924	cetylpyridinium chloride 0.07 % Oral Rinse	SY	14

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c6f86816-7da6-43ea-8c25-ac9758311cc5	Product name	1	20220118
3c386306-c48a-413e-bb69-70cb268496f3	Product name	1	20210727
252e11b6-1a9a-4283-a242-df2c129c496d	Product name	3	20170717

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
53942-299-86	Antispetic	1000 mL in 1 BOTTLE, PLASTIC	LIQUID	1000		14

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
CETYLPYRIDINIUM CHLORIDE	ACTIVE INGREDIENT	D9OM4SK49P	1
CETYLPYRIDINIUM	ACTIVE MOIETY	CUB7JI0JV3	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	1
POLOXAMER 188	INACTIVE INGREDIENT	LQA7B6G8JG	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	1
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	1
SACCHARIN SODIUM	INACTIVE INGREDIENT	SB8ZUX40TY	1
SUCRALOSE	INACTIVE INGREDIENT	96K6UQ3ZD4	1
water	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

Antispetic
Cetylpyridinium chloride
WATER
GLYCERIN
POLOXAMER 188
SACCHARIN SODIUM
PROPYLENE GLYCOL
SODIUM BENZOATE
SUCRALOSE
BENZOIC ACID
FD&C BLUE NO. 1
CETYLPYRIDINIUM

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
53942-299	53942-299-86

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
WATER	059QF0KO0R	IACT
GLYCERIN	PDC6A3C0OX	IACT
POLOXAMER 188	LQA7B6G8JG	IACT
SACCHARIN SODIUM	SB8ZUX40TY	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
SODIUM BENZOATE	OJ245FE5EU	IACT
SUCRALOSE	96K6UQ3ZD4	IACT
BENZOIC ACID	8SKN0B0MIM	IACT
FD&C BLUE NO. 1	H3R47K3TBD	IACT
CETYLPYRIDINIUM CHLORIDE	D9OM4SK49P	ACTIB

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 78 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	CONCENTRATE / ORAL		3 mg	Exact identifier — unii+route 30 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	FILM, SOLUBLE / ORAL		33 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SACCHARIN SODIUM	SACCHARIN SODIUM	SB8ZUX40TY	LIQUID / ORAL		3 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	GRANULE / ORAL	5.4 mg		Exact identifier — unii+route 36 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	SOLUTION / ORAL		1800 mg	Exact identifier — unii+route 30 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	TABLET, COATED / ORAL	3 mg		Exact identifier — unii+route 30 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	TROCHE / ORAL		60 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	SUSPENSION, EXTENDED RELEASE / ORAL		16 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	TABLET, CHEWABLE / ORAL		28 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	TABLET, EFFERVESCENT / ORAL		1080 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	SYRUP / ORAL		80 mg	Exact identifier — unii+route 36 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	GRANULE, FOR SOLUTION / ORAL		624 mg	Exact identifier — unii+route 30 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	FILM, SOLUBLE / ORAL		33 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	SOLUTION / ORAL		800 mg	Exact identifier — unii+route 36 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	TABLET, DELAYED RELEASE / ORAL		6 mg	Exact identifier — unii+route 30 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	CAPSULE, DELAYED RELEASE / ORAL		18 mg	Exact identifier — unii+route 30 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	CONCENTRATE / ORAL		3 mg	Exact identifier — unii+route 30 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	LIQUID / ORAL		29008 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	TROCHE / ORAL		60 mg	Exact identifier — unii+route 36 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	GRANULE / ORAL		81 mg	Exact identifier — unii+route 30 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	LIQUID / ORAL		2400 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	FILM / ORAL		1 mg	Exact identifier — unii+route 36 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	CAPSULE, DELAYED RELEASE / ORAL		18 mg	Exact identifier — unii+route 30 equally ranked IID candidates
SACCHARIN SODIUM	SACCHARIN SODIUM	SB8ZUX40TY	LIQUID / ORAL		3 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	SUSPENSION / ORAL		383 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	FILM / ORAL		1 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	SUSPENSION, EXTENDED RELEASE / ORAL		16 mg	Exact identifier — unii+route 36 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	POWDER, FOR SUSPENSION / ORAL		30 mg	Exact identifier — unii+route 30 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	LIQUID / ORAL		2 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	SOLUTION / ORAL		800 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	SUSPENSION / ORAL		383 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	POWDER, FOR SUSPENSION / ORAL		400 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	TABLET, FOR SUSPENSION / ORAL		65 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	GRANULE, FOR SUSPENSION / ORAL		23 mg	Exact identifier — unii+route 36 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	TABLET, FILM COATED / ORAL		3 mg	Exact identifier — unii+route 30 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	TABLET, FILM COATED / ORAL		3 mg	Exact identifier — unii+route 30 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	POWDER, FOR SOLUTION / ORAL		500 mg	Exact identifier — unii+route 30 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	TABLET, EXTENDED RELEASE / ORAL		1 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	TABLET, ORALLY DISINTEGRATING / ORAL		60 mg	Exact identifier — unii+route 36 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	TABLET, COATED / ORAL	3 mg		Exact identifier — unii+route 30 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	TABLET / ORAL		100 mg	Exact identifier — unii+route 30 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	POWDER, FOR SOLUTION / ORAL		414 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	LOZENGE / ORAL		115 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	TABLET, EXTENDED RELEASE / ORAL		1 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	LOZENGE / ORAL		115 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	GRANULE, FOR SUSPENSION / ORAL		23 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	POWDER, FOR SOLUTION / ORAL		414 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	TABLET, EFFERVESCENT / ORAL		1080 mg	Exact identifier — unii+route 36 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	CAPSULE / ORAL		151 mg	Exact identifier — unii+route 30 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	SUSPENSION / ORAL		1600 mg	Exact identifier — unii+route 30 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	TABLET, FOR SUSPENSION / ORAL		65 mg	Exact identifier — unii+route 36 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	CAPSULE / ORAL		151 mg	Exact identifier — unii+route 30 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	LIQUID / ORAL		2 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	LIQUID / ORAL		2400 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	POWDER, FOR SOLUTION / ORAL		500 mg	Exact identifier — unii+route 30 equally ranked IID candidates
FD&C BLUE NO. 1	FD&C BLUE NO. 1	H3R47K3TBD	LIQUID / ORAL	NA		Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	SUSPENSION / ORAL		1600 mg	Exact identifier — unii+route 30 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	POWDER, FOR SUSPENSION / ORAL		400 mg	Exact identifier — unii+route 36 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	SOLUTION / ORAL		1800 mg	Exact identifier — unii+route 30 equally ranked IID candidates
POLOXAMER 188	POLOXAMER 188	LQA7B6G8JG	GRANULE, FOR SOLUTION / ORAL		624 mg	Exact identifier — unii+route 30 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Antispetic	CETYLPYRIDINIUM CHLORIDE	Demoulas Super Markets, Inc	0162bc02-9c93-4f15-883c-68794c92e64d	2026-02-03	Warnings, Adverse reactions	Exact identifier ndc (package): 53942-299-86 ndc (product): 53942-299 ndc11 (package): 53942029986 spl id: 49ef6843-fbfb-84f2-e063-6294a90a1c77 spl set id: 0162bc02-9c93-4f15-883c-68794c92e64d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.